Fifth Third Bancorp »

Parabilis Medicines shares owned by Fifth Third Bancorp

Quarter-by-quarter ownership of Parabilis Medicines shares owned by Fifth Third Bancorp from 13F filings

Historical chart of Fifth Third Bancorp investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by Fifth Third Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by Fifth Third Bancorp

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.6k 60 27.35

More positions owned by Fifth Third Bancorp

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr S&p 100 Etf (OEF)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core Msci Eafe (IEFA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Meta Platforms Cl A (META)
Caterpillar (CAT)

View all positions for Fifth Third Bancorp

Top funds holding Parabilis Medicines

Regeneron Pharmaceuticals
TD Asset Management
China Universal Asset Management
Parallel Advisors
EverSource Wealth Advisors
Efficient Wealth Management
Fifth Third Bancorp
North Star Investment Management
Bogart Wealth

View all funds holding Parabilis Medicines